EPHB6 and thyroid gland carcinoma: Consistent with the result exhibited in Figure 1A, EPHB6 expression was found to have a significantly negative correlation with immunomodulatory genes expression in mesonephric adenocarcinoma (MESO), thyroid carcinoma (THCA), thymoma (THYM), and BLCA.